PATENT CLAIM ANALYSIS

Application Number: 15950545
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "210020"]

Abstract:
The present invention provides compounds and compositions that inhibit Factor XIa or kallikrein and methods of using these compounds and composition.

Claim (Index 22):
A pharmaceutically acceptable salt of a compound having the structure

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15290565', '14614169', '11398438', '15380836', '13703250']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.763079807389877
- 35 USC 102 Novelty (BERT): 0.5419776095963198
- Combined Prediction Score: 0.7409695876105213
- Mean Citation Score: 298.136036
- Max Citation Score: 367.05212
- Similarity Product: 278.62461159161563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test